HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab.

Saved in:
Bibliographic Details
Title: HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab.
Authors: Sánchez-Bayona R; Hospital Universitario 12 de Octubre, Madrid, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain., Martínez-Sáez O; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain., Romero-Romero D; Hospital Universitario 12 de Octubre, Madrid, Spain., Seguí E; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain., Carcelero E; Pharmacy Department, Hospital Clinic, Barcelona, Spain., Tolosa P; Hospital Universitario 12 de Octubre, Madrid, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain., Soberino J; Breast Cancer Unit, IOB-QuirónSalud, Barcelona, Spain., Alva M; Hospital Universitario 12 de Octubre, Madrid, Spain., Pascual T; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain., Lema L; Hospital Universitario 12 de Octubre, Madrid, Spain., Garcia-Fructuoso I; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain., Cobos-Fernandez MA; Hospital Universitario 12 de Octubre, Madrid, Spain., Rey M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain., Manso L; Hospital Universitario 12 de Octubre, Madrid, Spain., Aguirre A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain., Madariaga A; Hospital Universitario 12 de Octubre, Madrid, Spain., Sirenko V; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain., González-Deza C; Hospital Universitario 12 de Octubre, Madrid, Spain., Blasco P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain., Mayhua A; Hospital Universitario 12 de Octubre, Madrid, Spain., Castillo O; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain., Galván P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain., Sanfeliu E; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Pathology Department, Hospital Clínic de Barcelona, Barcelona, Spain., Villacampa G; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Buckingham W; Reveal Genomics, Barcelona, Spain., Marín-Aguilera M; Reveal Genomics, Barcelona, Spain., Paré L; Reveal Genomics, Barcelona, Spain., Villagrasa P; Reveal Genomics, Barcelona, Spain., Perou CM; Reveal Genomics, Barcelona, Spain., Maues J; GRASP, Baltimore, MD, USA., Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.; Reveal Genomics, Barcelona, Spain., Ciruelos E; Hospital Universitario 12 de Octubre, Madrid, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Centro Integral Oncológico Clara Campal HM (CIOCC), Madrid, Spain., Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. alprat@clinic.cat.; Medicine Department, University of Barcelona, Barcelona, Spain. alprat@clinic.cat.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain. alprat@clinic.cat.; Reveal Genomics, Barcelona, Spain. alprat@clinic.cat.
Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Apr 25; Vol. 11 (1), pp. 37. Date of Electronic Publication: 2025 Apr 25.
Publication Type: Journal Article
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40280938
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sánchez-Bayona+R%22">Sánchez-Bayona R</searchLink>; Hospital Universitario 12 de Octubre, Madrid, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez-Sáez+O%22">Martínez-Sáez O</searchLink>; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Romero-Romero+D%22">Romero-Romero D</searchLink>; Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Seguí+E%22">Seguí E</searchLink>; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Carcelero+E%22">Carcelero E</searchLink>; Pharmacy Department, Hospital Clinic, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Tolosa+P%22">Tolosa P</searchLink>; Hospital Universitario 12 de Octubre, Madrid, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Soberino+J%22">Soberino J</searchLink>; Breast Cancer Unit, IOB-QuirónSalud, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Alva+M%22">Alva M</searchLink>; Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pascual+T%22">Pascual T</searchLink>; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Lema+L%22">Lema L</searchLink>; Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Garcia-Fructuoso+I%22">Garcia-Fructuoso I</searchLink>; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Medicine Department, University of Barcelona, Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cobos-Fernandez+MA%22">Cobos-Fernandez MA</searchLink>; Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rey+M%22">Rey M</searchLink>; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Manso+L%22">Manso L</searchLink>; Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Aguirre+A%22">Aguirre A</searchLink>; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Madariaga+A%22">Madariaga A</searchLink>; Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sirenko+V%22">Sirenko V</searchLink>; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22González-Deza+C%22">González-Deza C</searchLink>; Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Blasco+P%22">Blasco P</searchLink>; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mayhua+A%22">Mayhua A</searchLink>; Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Castillo+O%22">Castillo O</searchLink>; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Galván+P%22">Galván P</searchLink>; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sanfeliu+E%22">Sanfeliu E</searchLink>; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Pathology Department, Hospital Clínic de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Villacampa+G%22">Villacampa G</searchLink>; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Buckingham+W%22">Buckingham W</searchLink>; Reveal Genomics, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Marín-Aguilera+M%22">Marín-Aguilera M</searchLink>; Reveal Genomics, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Paré+L%22">Paré L</searchLink>; Reveal Genomics, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Villagrasa+P%22">Villagrasa P</searchLink>; Reveal Genomics, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Perou+CM%22">Perou CM</searchLink>; Reveal Genomics, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Maues+J%22">Maues J</searchLink>; GRASP, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Brasó-Maristany+F%22">Brasó-Maristany F</searchLink>; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain.; Reveal Genomics, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ciruelos+E%22">Ciruelos E</searchLink>; Hospital Universitario 12 de Octubre, Madrid, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Centro Integral Oncológico Clara Campal HM (CIOCC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Prat+A%22">Prat A</searchLink>; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. alprat@clinic.cat.; Medicine Department, University of Barcelona, Barcelona, Spain. alprat@clinic.cat.; Cancer Institute and Blood Disorders, Hospital Clinic, Barcelona, Spain. alprat@clinic.cat.; Reveal Genomics, Barcelona, Spain. alprat@clinic.cat.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2025 Apr 25; Vol. 11 (1), pp. 37. <i>Date of Electronic Publication: </i>2025 Apr 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40280938
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41523-025-00753-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 37
    Titles:
      – TitleFull: HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sánchez-Bayona R
      – PersonEntity:
          Name:
            NameFull: Martínez-Sáez O
      – PersonEntity:
          Name:
            NameFull: Romero-Romero D
      – PersonEntity:
          Name:
            NameFull: Seguí E
      – PersonEntity:
          Name:
            NameFull: Carcelero E
      – PersonEntity:
          Name:
            NameFull: Tolosa P
      – PersonEntity:
          Name:
            NameFull: Soberino J
      – PersonEntity:
          Name:
            NameFull: Alva M
      – PersonEntity:
          Name:
            NameFull: Pascual T
      – PersonEntity:
          Name:
            NameFull: Lema L
      – PersonEntity:
          Name:
            NameFull: Garcia-Fructuoso I
      – PersonEntity:
          Name:
            NameFull: Cobos-Fernandez MA
      – PersonEntity:
          Name:
            NameFull: Rey M
      – PersonEntity:
          Name:
            NameFull: Manso L
      – PersonEntity:
          Name:
            NameFull: Aguirre A
      – PersonEntity:
          Name:
            NameFull: Madariaga A
      – PersonEntity:
          Name:
            NameFull: Sirenko V
      – PersonEntity:
          Name:
            NameFull: González-Deza C
      – PersonEntity:
          Name:
            NameFull: Blasco P
      – PersonEntity:
          Name:
            NameFull: Mayhua A
      – PersonEntity:
          Name:
            NameFull: Castillo O
      – PersonEntity:
          Name:
            NameFull: Galván P
      – PersonEntity:
          Name:
            NameFull: Sanfeliu E
      – PersonEntity:
          Name:
            NameFull: Villacampa G
      – PersonEntity:
          Name:
            NameFull: Buckingham W
      – PersonEntity:
          Name:
            NameFull: Marín-Aguilera M
      – PersonEntity:
          Name:
            NameFull: Paré L
      – PersonEntity:
          Name:
            NameFull: Villagrasa P
      – PersonEntity:
          Name:
            NameFull: Perou CM
      – PersonEntity:
          Name:
            NameFull: Maues J
      – PersonEntity:
          Name:
            NameFull: Brasó-Maristany F
      – PersonEntity:
          Name:
            NameFull: Ciruelos E
      – PersonEntity:
          Name:
            NameFull: Prat A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 04
              Text: 2025 Apr 25
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2374-4677
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ breast cancer
              Type: main
ResultId 1